| Dr Yun-sen Ralph Chu, MD | |
|
9117 Lyndale Ave S, Bloomington, MN 55420-3522 | |
| (952) 835-1235 | |
| (952) 835-1092 |
| Full Name | Dr Yun-sen Ralph Chu |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 32 Years |
| Location | 9117 Lyndale Ave S, Bloomington, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659367423 | NPI | - | NPPES |
| 288517400 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 38792 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chu Laser Eye Institute, Pa | 4082644786 | 5 |
News Archive
Diseases such as bone cancer and osteoporosis are frequently complex, with two or more disorders occurring simultaneously.
Open Monoclonal Technology, Inc. (OMT) today announced an antibody discovery collaboration with Merck KGaA. OMT and Merck KGaA have entered into a collaboration whereby OMT will use its OmniRats to generate antibodies against several targets selected by Merck KGaA.
Ancora Pharmaceuticals announced today that it received two federal grants under the Qualifying Therapeutic Discovery Program to continue funding its groundbreaking research and development of vaccine candidates to prevent malaria and infection by staphylococcus aureus.
The H1N1 influenza pandemic has led to a sharp increase in the number of children with a serious "secondary" bacterial infection called empyema in children, suggests a study in the October issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.
› Verified 5 days ago
| Entity Name | Chu Laser Eye Institute, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407977762 PECOS PAC ID: 4082644786 Enrollment ID: O20050812000430 |
News Archive
Diseases such as bone cancer and osteoporosis are frequently complex, with two or more disorders occurring simultaneously.
Open Monoclonal Technology, Inc. (OMT) today announced an antibody discovery collaboration with Merck KGaA. OMT and Merck KGaA have entered into a collaboration whereby OMT will use its OmniRats to generate antibodies against several targets selected by Merck KGaA.
Ancora Pharmaceuticals announced today that it received two federal grants under the Qualifying Therapeutic Discovery Program to continue funding its groundbreaking research and development of vaccine candidates to prevent malaria and infection by staphylococcus aureus.
The H1N1 influenza pandemic has led to a sharp increase in the number of children with a serious "secondary" bacterial infection called empyema in children, suggests a study in the October issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yun-sen Ralph Chu, MD 9117 Lyndale Ave S, Bloomington, MN 55420-3522 Ph: (952) 835-1235 | Dr Yun-sen Ralph Chu, MD 9117 Lyndale Ave S, Bloomington, MN 55420-3522 Ph: (952) 835-1235 |
News Archive
Diseases such as bone cancer and osteoporosis are frequently complex, with two or more disorders occurring simultaneously.
Open Monoclonal Technology, Inc. (OMT) today announced an antibody discovery collaboration with Merck KGaA. OMT and Merck KGaA have entered into a collaboration whereby OMT will use its OmniRats to generate antibodies against several targets selected by Merck KGaA.
Ancora Pharmaceuticals announced today that it received two federal grants under the Qualifying Therapeutic Discovery Program to continue funding its groundbreaking research and development of vaccine candidates to prevent malaria and infection by staphylococcus aureus.
The H1N1 influenza pandemic has led to a sharp increase in the number of children with a serious "secondary" bacterial infection called empyema in children, suggests a study in the October issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.
› Verified 5 days ago
Honora E. Kennedy, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 9801 Dupont Ave S Ste 200, Bloomington, MN 55431 Phone: 952-888-5800 Fax: 952-567-6156 | |
Mehdi Roozbahani, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 9801 Dupont Ave S Ste 110, Bloomington, MN 55431 Phone: 612-355-6510 Fax: 612-713-9360 | |
Kaihan Fakhar, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8600 Nicollet Ave S, Bloomington, MN 55420 Phone: 952-541-2800 Fax: 952-886-7015 | |
Elizabeth A Davis, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9801 Dupont Ave S, Suite 200, Bloomington, MN 55431 Phone: 952-888-5800 Fax: 952-884-2656 | |
Jefferson Berryman, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9801 Dupont Ave S Ste 200, Bloomington, MN 55431 Phone: 952-888-5800 Fax: 952-567-6156 | |
Jill Suzanne Melicher Larson, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9801 Dupont Ave S, 200, Bloomington, MN 55431 Phone: 952-888-5800 | |
Thomas Lang, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7920 Old Cedar Ave S, Bloomington, MN 55425 Phone: 952-428-1800 |